Tumor vasculature as a therapeutic target in non-small cell lung cancer.

Abstract

INTRODUCTION We aim to describe the molecular mechanisms relevant to angiogenesis inhibition and to critically evaluate the current evidence for the use of angiogenic inhibitors (AIs) in the treatment of non-small cell lung cancer (NSCLC). METHODS The literature on the basic concepts of tumor angiogenesis is reviewed. Published articles and major lung… (More)
DOI: 10.1097/JTO.0b013e3182435f3e

Topics

1 Figure or Table

Cite this paper

@article{Bar2008TumorVA, title={Tumor vasculature as a therapeutic target in non-small cell lung cancer.}, author={Jair Bar and Glenwood D Goss}, journal={Magyar onkologia}, year={2008}, volume={52 3}, pages={247-59} }